Research ArticleComplications
Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes
Cristina Hernández, Patricia Bogdanov, Lidia Corraliza, Marta García-Ramírez, Cristina Solà-Adell, José A. Arranz, Ana I. Arroba, Angela M. Valverde, Rafael Simó
DOI: 10.2337/db15-0443 Published 1 January 2016
Cristina Hernández
1Diabetes and Metabolism Research Unit, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain
Patricia Bogdanov
1Diabetes and Metabolism Research Unit, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain
Lidia Corraliza
1Diabetes and Metabolism Research Unit, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain
Marta García-Ramírez
1Diabetes and Metabolism Research Unit, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain
Cristina Solà-Adell
1Diabetes and Metabolism Research Unit, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain
José A. Arranz
3Unidad de Metabolopatías, Laboratorios Clínicos, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Ana I. Arroba
2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain
4Instituto de Investigaciones Biomédicas “Alberto Sols,” Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid, Madrid, Spain
Angela M. Valverde
2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain
4Instituto de Investigaciones Biomédicas “Alberto Sols,” Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid, Madrid, Spain
Rafael Simó
1Diabetes and Metabolism Research Unit, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
2CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain